Adherence to delayed-release cysteamine in nephropathic cystinosis over time: data from the prospective CrYSTobs cohort study.
隨著時間推移,對於腎病性胱氨酸尿症的延遲釋放胱氨酸的遵從性:來自前瞻性 CrYSTobs 隊列研究的數據。
Pediatr Nephrol 2025-02-04
Antihypertensive medication nonadherence and target organ damage in children with chronic kidney disease.
慢性腎臟疾病兒童抗高血壓藥物不依從與靶器官損傷。
Pediatr Nephrol 2024-02-18
Worldwide disparities in access to treatment and investigations for nephropathic cystinosis: a 2023 perspective.
全球對腎病性囊腫症治療和檢查的存取不平等:2023年的觀點。
Pediatr Nephrol 2024-03-01
Switching from immediate- to extended-release cysteamine in patients with nephropathic cystinosis: from clinical trials to clinical practice.
將腎病性囊狀病變患者從即時型半胱氨酸轉換為延長型半胱氨酸:從臨床試驗到臨床實踐。
Clin Kidney J 2024-04-18
Tafamidis medication adherence and persistence in patients with transthyretin amyloid cardiomyopathy in Japan.
Tafamidis 藥物依從性及持續性在日本具有甲狀腺素運輸蛋白淀粉样心肌病的患者中。
ESC Heart Fail 2024-05-24
Morphological changes and their associations with clinical parameters in children with nephropathic cystinosis and chronic kidney disease prior to kidney replacement therapy over 25 years.
嬰兒囊性胱氨酸沉積症和慢性腎臟病童在腎臟替代治療前25年的形態學變化及其與臨床參數的關聯。
Pediatr Nephrol 2024-06-08
Adherence patterns 1 year after initiation of SGLT2 inhibitors: results of a national cohort study.
SGLT2 抑制劑啟動後一年遵從性模式:全國性隊列研究結果。
Am J Manag Care 2024-08-15